Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies (opens in new window) for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Manage cookies
Accept & continue
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
myFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • Americas
    • Middle East and North Africa
    Most Read
    • Germany pushes back on AstraZeneca vaccine efficacy reports
    • How Israel secured more vaccines than it can use
    • Foreign workers flee UK as pandemic and Brexit bite
    • UK residents flying back from Covid hotspots face hotel quarantine
    • Germany presses Brussels for powers to block vaccine exports
  • US
    Sections
    • US Home
    • US Economy
    • US Companies
    • US Politics & Policy
    Most Read
    • ‘Here is Cyrus Vance’s moment’: Donald Trump’s new legal nemesis
    • Reddit traders wage battle against Wall Street 
    • Why did Leon Black pay $158m to Jeffrey Epstein?
    • Nearly all Republicans back Trump in early impeachment test
    • Fox News held talks with former White House press secretary
  • Companies
    Sections
    • Companies Home
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
    Most Read
    • Black steps down as Apollo CEO after report into payments to Epstein
    • Why did Leon Black pay $158m to Jeffrey Epstein?
    • Fox News held talks with former White House press secretary
    • UniCredit chooses Andrea Orcel as chief executive
    • Global chip shortage puts car supply chain under the microscope
  • Tech
  • Markets
    Sections
    • Markets Home
    • Alphaville
    • Markets Data
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
    Most Read
    • Companies raise $400bn over three weeks in blistering start to 2021
    • Investor anxiety mounts over prospect of stock market ‘bubble’
    • Retail investors rush to find the next stock market unicorn
    • Runaway Markets
    • Spac mania, Apollo’s Leon Black steps down, what’s fuelling the Russia protests
  • Climate
  • Opinion
    Sections
    • Opinion Home
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
    Most Read
    • Vaccines have been oversold as the pandemic exit strategy
    • ‘Lazy’ Britons aren’t the reason for the UK’s migrant workforce
    • Retail investors rush to find the next stock market unicorn
    • Joe Biden must choose between unity and change
    • Vaccine protectionism by the EU will backfire
  • Work & Careers
    Sections
    • Work & Careers Home
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
    Most Read
    • Why you should ditch ‘follow your passion’ careers advice
    • Why women are turning away from MBAs
    • A bracing collection of salvos on the ‘new Great Depression’
    • Family businesses are welcome winners in the pandemic
    • Could do better: the need for tougher board reviews
  • Life & Arts
    Sections
    • Life & Arts Home
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
    Most Read
    • Atlantic star: the 21-year-old woman rowing the ocean alone
    • Covid and me: 10 days on life support  | Free to read
    • Goodbye loungewear: Paris designers dream up clothes for normal life
    • How China’s delivery apps are putting riders at risk
    • Portrait of a park: Paris’s Jardin du Luxembourg — a trail of the unexpected
  • How to Spend It
  • Sign In
  • Subscribe
MenuSearch
  • Home
  • World
  • US
  • Companies
  • Tech
  • Markets
  • Climate
  • Opinion
  • Work & Careers
  • Life & Arts
  • How to Spend It
Financial Times
  • Sign In
  • Subscribe

$50 for your first 3 months Get the print edition and steer from crisis to recovery

Subscribe now

Health

Add to myFT Digest

Add this topic to your myFT Digest for news straight to your inbox

  • Wednesday, 27 January, 2021
    Coronavirus pandemic
    Coronavirus latest: Mexico’s Covid death toll may be higher than previously thought
    new
  • Wednesday, 27 January, 2021
    Spain
    Madrid region to halt new vaccinations as supplies run out

    Move highlights EU’s mounting problems with coronavirus vaccine rollout

    2 hours ago
  • Wednesday, 27 January, 2021
    Covid-19 vaccines
    EU says AstraZeneca must supply Covid vaccines from its UK plants

    Contract with drugmaker entitles bloc to production from its British facilities, say officials

    2 hours ago
  • Wednesday, 27 January, 2021
    Global Economy
    IMF warns on financial stability threat from vaccine shortages

    Lack of access to jabs in emerging markets could have global consequences, fund says

    3 hours ago
  • Wednesday, 27 January, 2021
    Coronavirus treatment
    Lead Covid antibody test developer has government orders cancelled

    Abingdon Health omits UK health department’s move from trading update

  • Wednesday, 27 January, 2021
    Covid-19 vaccines
    UK orders study into how much vaccines cut Covid transmission

    Findings will play big role in determining how quickly lockdown is lifted, officials say

  • Wednesday, 27 January, 2021
    Lex
    Lex letter from London: flag ends Premium

    Rollout of Covid jabs has brought vaccine nationalism back on to the agenda

  • Wednesday, 27 January, 2021
    World Economic Forum
    Davos highlights: Putin warns of ‘all against all’ fight if global development is neglected

    Israel’s leader sees long race ahead between Covid vaccinations and mutations

  • Wednesday, 27 January, 2021
    ExplainerCovid-19 vaccines
    Vaccine export rules: what is the EU proposing?

    Worries grow in bloc over supply shortfalls and rollout in member states

  • Promoted Content
  • Wednesday, 27 January, 2021
    Special ReportBusiness and Society
    Invention is the mother of profitability

    New technologies can bring benefits both to the poorest parts of the planet and to investors

  • Wednesday, 27 January, 2021
    Walgreens Boots Alliance Inc
    Walgreens Boots Alliance recruits new chief from Starbucks

    Roz Brewer will become only black woman to run an S&P 500 company

  • Wednesday, 27 January, 2021
    Covid-19 vaccines
    Japan insists on domestic clinical trials before vaccine rollout

    Covid-19 inoculation campaign delayed by Tokyo’s demand for Japan-specific data

  • Tuesday, 26 January, 2021
    Covid-19 vaccines
    Brazilian companies discuss seeking direct vaccine supplies

    Despite Bolsonaro’s support, AstraZeneca says it does not currently sell jabs to private sector

  • Tuesday, 26 January, 2021
    News in-depthCovid-19 vaccines
    If Covid vaccines stop working, how quickly can drugmakers respond?

    Pharmaceutical industry faces new race as worrying variants emerge

  • Tuesday, 26 January, 2021
    Covid-19 vaccines
    Germany presses EU for powers to block vaccine exports

    Mounting pressure over sluggish start to vaccinations and shortages of doses

  • Tuesday, 26 January, 2021
    The FT ViewThe editorial board
    Vaccine protectionism by the EU will backfire

    More transparency on pharmaceutical deals is needed but an export ban is not

  • Tuesday, 26 January, 2021
    Covid-19 vaccines
    Germany pushes back on AstraZeneca vaccine efficacy reports

    Health ministry suggests media muddled statistics in concluding efficacy rates were as low as 8% in over 65s

  • Tuesday, 26 January, 2021
    Amy Kazmin
    Narendra Modi’s ‘noble’ wait for a Covid jab makes him camera shy

    Indian PM’s reluctance to offer a vaccination photo-opportunity fuels speculation over his motive

  • Tuesday, 26 January, 2021
    Johnson & Johnson Co Inc
    Johnson & Johnson confident of rebound as vaccines offer boost for healthcare

    Phase 3 trial data for its candidate due to be released early next week

  • Tuesday, 26 January, 2021
    Covid-19 vaccines
    Imperial College to target coronavirus mutations

    London university ditches plans for efficacy trial to focus on developing next-generation jabs

  • Tuesday, 26 January, 2021
    Coronavirus economic impact
    IMF expects US and China to recover most strongly from virus economic hit

    Fund predicts that Europe and emerging markets will be lagging behind in 2022

  • Tuesday, 26 January, 2021
    Covid-19 vaccines
    Covid vaccine development: The shots available and the doses administered

    After a year of breakneck research and development, inoculations have begun

  • Tuesday, 26 January, 2021
    Denmark
    Denmark offers mink farmers more than $3bn in Covid compensation

    Botched cull of up to 17m animals over fears of virus mutation sparked anger against government

  • Tuesday, 26 January, 2021
    Coronavirus pandemic
    Chinese city suffers food shortages during Covid-19 lockdown

    Officials in Tonghua battle rare public outcry over late deliveries of daily necessities

  • Tuesday, 26 January, 2021
    Anjana Ahuja
    Vaccines have been oversold as the pandemic exit strategy

    Covid will be around for a long time — virus suppression is the right policy

Previous You are on page 1 Next

Useful links

Support

View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

Legal & Privacy

Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

Services

FT LiveShare News Tips SecurelyIndividual SubscriptionsGroup SubscriptionsRepublishingContracts & Tenders
Executive Job SearchAdvertise with the FTFollow the FT on TwitterFT TransactSecondary Schools

Tools

PortfolioToday's Newspaper (ePaper)Alerts HubBusiness School Rankings
Enterprise ToolsNews feedNewslettersCurrency Converter
More from the FT Group
Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2021. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
Financial Times

International Edition

  • Switch to UK Edition
  • Top sections
  • Home
  • World
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • Americas
    • Middle East and North Africa
  • US
    • US Economy
    • US Companies
    • US Politics & Policy
  • Companies
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
  • Tech
  • Markets
    • Alphaville
    • Markets Data
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
  • Climate
  • Opinion
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
  • Work & Careers
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
  • Life & Arts
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
  • Personal Finance
    • Property & Mortgages
    • Investments
    • Pensions
    • Tax
    • Banking & Savings
    • Advice & Comment
    • Next Act
  • How to Spend It
  • Special Reports
  • FT recommends
  • Graphics
  • Lex
  • Alphaville
  • Lunch with the FT
  • FT Globetrotter
  • #techAsia
  • Moral Money
  • FTfm
  • Newsletters
  • Video
  • Podcasts
  • News feed
  • myFT
  • Portfolio
  • Today's Newspaper (ePaper)
  • Crossword
  • Our Apps
  • Help Centre
  • Subscribe
  • Sign In